Cargando…
CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research
Cancer is one of the most leading causes of mortalities worldwide. It is caused by the accumulation of genetic and epigenetic alterations in 2 types of genes: tumor suppressor genes (TSGs) and proto-oncogenes. In recent years, development of the clustered regularly interspaced short palindromic repe...
Autores principales: | Yang, Yue, Xu, Jin, Ge, Shuyu, Lai, Liqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7965951/ https://www.ncbi.nlm.nih.gov/pubmed/33748164 http://dx.doi.org/10.3389/fmed.2021.649896 |
Ejemplares similares
-
Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2023) -
Applications and Research Advances in the Delivery of CRISPR/Cas9 Systems for the Treatment of Inherited Diseases
por: Lu, Xinyue, et al.
Publicado: (2023) -
New advances in CRISPR/Cas-mediated precise gene-editing techniques
por: Richardson, Chris, et al.
Publicado: (2023) -
Current trends of clinical trials involving CRISPR/Cas systems
por: Zhang, Songyang, et al.
Publicado: (2023) -
Applications of CRISPR-Cas9 for advancing precision medicine in oncology: from target discovery to disease modeling
por: Ravichandran, Mirunalini, et al.
Publicado: (2023)